LeanLife Health Inc. was born from a desire to offer high quality omega3 plant-based oils to the world. Evidence of over 50 years supports the numerous health benefits of flaxseed omega 3 alpha-linolenic acid. LeanLife Health recognized that over 50% of North Americans do not consume enough omega 3 fats and eat far too many omega 6 fats. Our omega 3 flaxseed formulation is stable for 2 years which will allow more food companies to add the oil to their products and more consumers to meet their nutritional needs. Proprietary methods initially developed at a Polish University in 2007 have been continuously improved upon to result in the most nutritionally stable plant-based omega 3 oils that are on the market today.
We have engaged a team with global expertise in omega 3 science, production and direct to consumer marketing. Our professionals are working to ensure that our omega 3 flaxseed oil is the healthiest, the most stable and the most convenient available today.
The LeanLife Health team has extensive experience in all facets of management, finance, marketing, operations and biotechnology.
Chief Executive Officer
Mr. Lis was the co‐founder, past president and director of MicroCoal Technologies Inc. (formerly Carbon Friendly Solutions Inc.) from its inception in 2006 to 2015. From 2000 until 2006, he was the president, CEO and director of Stream Communications Network & Media Inc., a cable company where he was directly responsible for taking the company from start up to 65,000 subscribers. From 1993 until 2000, Mr. Lis acted as President, CEO and director of Trooper Technologies Inc., an environmental company focused on waste management in Central Europe. In 1988 he founded International UNP Holdings Ltd., a Toronto Stock Exchange Investment Company used to acquire and finance privatized Polish state enterprises. Mr. Lis studied Business Administration and Securities at Simon Fraser University. Mr. Lis personally raised over $60 million to finance the above mentioned companies.
Chief Operating Officer
Gavin Mah has been in the natural health products industry for over 33 years. His mission is to help people achieve optimal health and he is committed to finding and promoting premium high quality, clinically proven, safe and effective natural health products. Mr. Mah has extensive experience working with Regulatory Advisory and Government Relations Committees with Health Canada. For seven years, Mr. Mah served as Director of Canadian Regulatory Affairs at Nature's Way, a leading health company which sells its many nutritional and dietary supplements, including its Omega-3 products, through a variety of channels such as Walmart. He was instrumental in the acquisition of Ascenta Health, the leading Omega-3 fish oil manufacturer, by Nature's Way and its parent company Schwabe Pharma (Germany). Mr. Mah has also worked with and sold Omega-3 products for both Omega Nutrition and Barleans Oils, two of the largest flax oil companies in the Pacific Northwest. Mr. Mah will not only bring his 33 years of industry experience but also his corporate resources and extensive connections to the Company.
Interim Chief Financial Officer
James Casey Forward has been a CPA/CGA (professional accountant) in British Columbia since 1985. Mr. Forward has been a director, Chief Executive Officer and/or Chief Financial Officer of public companies trading on the CSE, the TSX and TSX Venture Stock Exchange in Canada, the OTCQX in the United States and as an executive of a PLC in the United Kingdom. Previously Mr. Forward was the president of a trucking and storage company, a partner in an accounting practice and the president of a construction company.
Carl F. Perez, PhD
Chief Technical Officer
Dr. Perez has more than 30 years of leadership in academic research programs and has experience in all phases of drug discovery, process development, preclinical development, FDA/Health Canada regulatory compliance, and cGMP manufacturing. Dr. Perez was Director Preclinical Programs for Chromos Molecular Systems (Burnaby, BC) and VP Product Development for Metaara Medical Technologies (Vancouver, BC).
Kelley Fitzpatrick, M.Sc.
Senior Business Advisor
Ms. Kelley Fitzpatrick is the principle of NutriScience Solutions which provides services in numerous areas in natural health products (NHP) and functional foods (FF). Ms. Fitzpatrick provides a unique and comprehensive perspective on the agriculture and health sector in Canada, having worked with all stakeholders including government, private industry, research, trade associations and as an entrepreneur for almost 30 years. Ms. Fitzpatrick was the project lead for Global Affairs Canada (GAC) Investment Case Study for the FFNHP categories. Kelley acts an investment champion speaker for GAC. During her consultancy, she has worked with eighty-one FF and ingredients, and NHP companies, and written one hundred and seventy-two reports/documents for clients within industry, government, academia and NGOs. She has secured over $200 million in funding for her clients and was one of the lead writers on a successful funding application that established Protein Industries Canada, one of five superclusters. Kelley is a recognized expert in flaxseed having led initiatives in research, marketing and promotional activities for over 20 years. Kelley has worked in the areas of human and animal health, industrial fibre and oil, and plant breeding and agronomy, first as the Project Manager for Flax Canada 2015 and then as a Technical Advisor for the Flax Council of Canada. During this period, she led the development of a successful dossier to the United States Food and Drug Administration for GRAS (Generally Recognized as Safe) notice for whole and milled flaxseed – GRN 000280 (2009). She also worked with Agriculture and Agri-Food Canada to develop a successful submission to Health Canada for a blood cholesterol lowering health claim for whole and milled flaxseed (2014). In 2020, Kelley was awarded the Outstanding Leadership Award in Biosciences by the BioScience Association of Manitoba. Ms. Fitzpatrick has published book chapters and articles specifically on Canadian regulations, the industry and the science of FFNHP and provided over 500 invited global presentations.
Board of Directors
Stan Lis, CEOSee above
Marcin Łukaszewicz, PhD
Dr. Łukaszewicz is the Dean of the Department of Biotransformation, at the Faculty of Biotechnology, University of Wroclaw (Poland). Dr. Łukaszewicz is an expert in molecular biology, biotechnology, and microbiology.
Glen Macdonald, Director
Mr. MacDonald is a self-employed geology consultant. Mr. Macdonald has served as CEO, President, and Director for numerous private and public companies with particular expertise in corporate development and fiduciary compliance.
Dr. Robert Chanson, Director
Dr. Robert Chanson is a Swiss National born in Sri Lanka (1950). Following Schooling in Ceylon and Switzerland, he studied Law & Ecology in Zurich, London and Paris. Robert is a Lawyer and holds a PhD in Environmental Sciences. Following a career in various management capacities with an internationally operating Swiss financial services Company he formed a pioneering risk-management company with a focus on environmental risks in the early 90s. Since the late 90s Robert has established himself as an Institutional Business Angel in the field of Biotech, Sustainable Agriculture and Renewable Energies entertaining projects both in Europe, North America and South Asia. He is a co-founder of the London-listed ag-biotech Company ‘Plant Health Care’ – his two latest start-ups focus on encryption technologies and a novel pyrolytic reactor. Dr. Chanson has joined the LeanLife team as an Independent Director to assist the Company in reaching its ambitious business goals in North America and Overseas.